Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Evonik To Dissolve China Joint Venture

by Jean-François Tremblay
April 23, 2012 | A version of this story appeared in Volume 90, Issue 17

Evonik Industries will exit its Evonik Sanzheng joint venture in China, according to Dahai Yu, a member of Evonik’s executive board. Yu declined to confirm a report in the German newspaper Handelsblatt that Evonik discovered improper payments and gifts at the joint venture, in which Evonik holds a 65% stake. In 2007, Evonik Sanzheng invested $35 million to build a cyanuric chloride plant in Chongqing. The venture also produces the intermediate chemical in Yingkou.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.